Profil
Jennifer A. Sanfilippo is currently Chief Compliance Officer & General Counsel at Melinta Therapeutics, Inc. Formerly, Ms. Sanfilippo was Chief Executive Officer at Rempex Pharmaceuticals, Inc. and Attorney at Porzio, Bromberg & Newman PC.
Ms. Sanfilippo completed undergraduate studies at New York University and graduate studies at Rutgers Law School.
Postes actifs de Jennifer Sanfilippo
| Sociétés | Poste | Début |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Compliance Officer | - |
Anciens postes connus de Jennifer Sanfilippo
| Sociétés | Poste | Fin |
|---|---|---|
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers new antibacterial drugs | Directeur Général | - |
Porzio, Bromberg & Newman PC
Porzio, Bromberg & Newman PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Formation de Jennifer Sanfilippo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Porzio, Bromberg & Newman PC
Porzio, Bromberg & Newman PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers new antibacterial drugs | Health Technology |
Rutgers Law School
Rutgers Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
















